On July 31, 2023, an amendment to New Jersey’s Unemployment Compensation Law that ostensibly seeks to streamline the benefits process went into effect. Governor Phil Murphy signed the amendment into law in November 2022.
Most
Continue Reading Changes to New Jersey’s Unemployment Compensation Law take effect July 31, 2023
In June 2023, the Treasury Department and the IRS issued long-awaited proposed regulations addressing transfers of green energy tax credits under the Inflation Reduction Act (IRA).
Prior to the IRA, a REIT typically held solar
Continue Reading IRS provides favorable guidance on REIT tax treatment of transferable renewable energy credits for rooftop solar panels and electric vehicle charging stations
Written by: Bethany Hills, Adam Donat
The Food and Drug Administration (FDA) has released a draft guidance titled, “Good Clinical Practice (GCP) E6(R3),” explaining how the Agency plans to apply its regulations
Continue Reading Guest Blog: FDA aims for international harmonization and modernized clinical trials
Against the backdrop of evolving state regulatory landscapes for controlled substances, including psychedelics for therapeutic uses, the US Food and Drug Administration (FDA) recently released a draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations
As companies consider the benefits of using generative artificial intelligence, they must also balance such benefits against certain legal and business risks.
This article explores possible frameworks for a policy that strategically leverages the benefits
Continue Reading Generative AI – framing a business-centric policy to address opportunities and risks
On June 27, 2023, the Federal Trade Commission (FTC), with the concurrence of the Department of Justice (DOJ), announced the most dramatic changes to the Hart-Scott-Rodino (HSR) Act Notification and Report Form since the program’s
FDA regulates prescription drug advertising under the authority of the Federal Food, Drug, and Cosmetic Act (FDCA) and the implementing regulations. In 2018, after observing an increase in quantitative presentations of efficacy and risk information
Continue Reading Key updates from FDA’s latest guidance on presenting efficacy and risk data in DTC promotion
The European Union’s Corporate Sustainability Reporting Directive (CSRD) is now in force, and its requirements take actual effect in a phased manner from 2024 onwards. According to global financial data provider Refinitiv’s study, the
Continue Reading EU’s Corporate Sustainability Reporting Directive: What US companies need to know
Written by:Meghan Carey, Jessica McKinney, Rommy Hage
The Securities and Exchange Commission (SEC) adopted amendments to Form Private Fund (Form PF), the confidential reporting form for certain SEC-registered investment advisers to private
Continue Reading Guest Blog: SEC significantly expands Form PF reporting requirements for private equity fund advisers and large hedge fund advisers
Written by: Christopher Cullen, Sam Tyner-Monroe, Tony Samp, Bennett Borden, Danny Tobey. Coran Darling
The Select Committee on Artificial Intelligence (AI) of the National Science and Technology Council has released its latest update to the
Continue Reading Guest Blog: The US National AI R&D Strategic Plan 2023: A comprehensive look into the future of AI
